A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis
Clinical trial NCT03945279 · COMPLETED
Trial details
- NCT number
- NCT03945279
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2021-06-21
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.